The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)

被引:120
作者
Noy, A. [1 ]
Schoeder, H. [6 ]
Goenen, M. [5 ]
Weissler, M. [2 ]
Ertelt, K. [3 ]
Cohler, C. [4 ]
Portlock, C. [1 ]
Hamlin, P. [1 ]
Yeung, H. W. D. [6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY 10065 USA
[2] Weill Cornell Med Ctr, Dept Med, New York, NY USA
[3] Humboldt Univ, Berlin, Germany
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Radiol Nucl Med, New York, NY 10065 USA
关键词
(18)fluoro-2-deoxyglucose (FDG); lymphoma; positron emission tomography (PET); standardized uptake value (SUV); transformation; NON-HODGKINS-LYMPHOMA; MALIGNANT-LYMPHOMA; FDG-PET; F-18-FLUORODEOXYGLUCOSE; CLASSIFICATION; DISEASE;
D O I
10.1093/annonc/mdn657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We previously correlated non-Hodgkin's lymphoma (NHL) histology with (18)fluoro-2-deoxyglucose-positron emission tomography (FDG-PET) intensity: a standardized uptake value (SUV) > 10 predicted aggressive lymphoma with > 80% certainty and an SUV > 13, with > 90% certainty. Patients and methods: To evaluate SUV in transformed lymphoma, we identified all FDG-PET scans for NHL at Memorial Sloan-Kettering Cancer 1999-2007 with (i) biopsy-proven transformation, (ii) no therapy 60 days before PET scan and (iii) FDG-PET scans no more than 60 days before or 90 days after transformation. Results: In 5 of 40 patients, the biopsy site was excised before PET; in two, only marrow was biopsied. In the remaining 33 patients, the SUV of the biopsy site ranged from 3 to 38, mean 14, median 12. Eighteen of 33 biopsies (55%) had an SUV > 10 and 16 (48%) > 13. The highest SUV in a transformed lymphoma PET scan (SUVstudy-max) ranged from 3.2 to 40, mean 15, median 12. Twenty-five of 40 patients (63%) presented with an SUVstudy-max > 10 and 20 (50%) > 13. Conclusions: Like de novo aggressive lymphomas, the majority of transformations have a high SUVstudy-max for a given pretreatment staging study, although many do not have very high values. Transformation should be suspected in indolent lymphoma with high SUVs on FDG-PET. Biopsies should be directed to the site of greatest FDG avidity.
引用
收藏
页码:508 / 512
页数:5
相关论文
共 16 条
  • [1] Buchmann I, 2001, CANCER, V91, P889
  • [2] Molecular Imaging of proliferation in malignant lymphoma
    Buck, Andreas K.
    Bommer, Martin
    Stilgenbauer, Stephan
    Juweid, Malik
    Glatting, Gerhard
    Schirrmeister, Holger
    Mattfeldt, Torsten
    Tepsic, Djurdja
    Bunjes, Donald
    Mottaghy, Felix M.
    Krause, Bernd J.
    Neumaier, Bernd
    Doehner, Hartmut
    Moeller, Peter
    Reske, Sven N.
    [J]. CANCER RESEARCH, 2006, 66 (22) : 11055 - 11061
  • [3] Detection of lymphoma in bone marrow by whole-body positron emission tomography
    Carr, R
    Barrington, SF
    Madan, B
    O'Doherty, MJ
    Saunders, CAB
    van der Walt, J
    Timothy, AR
    [J]. BLOOD, 1998, 91 (09) : 3340 - 3346
  • [4] Conover W.J., 2001, PRACTICAL NONPARAMET, V3
  • [5] The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma
    Gine, E.
    Montoto, S.
    Bosch, F.
    Arenillas, L.
    Mercadal, S.
    Villamor, N.
    Martinez, A.
    Colomo, L.
    Campo, E.
    Montserrat, E.
    Lopez-Guillermo, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (10) : 1539 - 1545
  • [6] World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997
    Harris, NL
    Jaffe, ES
    Diebold, J
    Flandrin, G
    Muller-Hermelink, HK
    Vardiman, J
    Lister, TA
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3835 - 3849
  • [7] Lymphoma classification - from controversy to consensus: The REAL and WHO Classification of lymphoid neoplasms
    Harris, NL
    Jaffe, ES
    Diebold, J
    Flandrin, G
    Muller-Hermelink, HK
    Vardiman, J
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 3 - 10
  • [8] Hoh CK, 1997, J NUCL MED, V38, P343
  • [9] Huang SC, 2000, NUCL MED BIOL, V27, P643
  • [10] Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
    Jerusalem, G
    Beguin, Y
    Fassotte, MF
    Najjar, F
    Paulus, P
    Rigo, P
    Fillet, G
    [J]. BLOOD, 1999, 94 (02) : 429 - 433